Episode #10: GLP-1, A VC’s Personal Experience

Tech Optimist Podcast — Tech, Entrepreneurship, and Innovation

Written by

Alumni Ventures

Published on

Read

2 min

In this episode of the Tech Optimist podcast, Grant Demeter interviews Mike Collins about his personal experience with Mounjaro. They discuss the drug’s impact on Mike’s health, the broader implications for the healthcare and investment sectors, and the future potential of GLP-1 treatments.

#10: GLP-1, A VC’s Personal Experience

See video policy below.

In this episode of the Tech Optimist podcast, host Grant Demeter and Mike Collins discuss Mike’s experience with Mounjaro, a GLP-1 weight loss drug. Mike shares his personal journey with the drug, its impact on his health, and broader implications for investment and healthcare. They also discuss impacts of personalized medicine, long-term effects, societal changes in food and fitness habits, and investment opportunities in the healthcare sector.

Watch Time ~36 minutes

The show is produced by Alumni Ventures, which has been recognized as a “Top 20 Venture Firm” by CB Insights (’24) and as the “#1 Most Active Venture Firm in the US” by Pitchbook (’22 & ’23).

READ THE FULL EPISODE TRANSCRIPT

Creators and Guests

HOST

Grant Demeter
Principal, Alumni Ventures

Grant is a Principal at Alumni Ventures, a network-powered Venture Capital firm. Entrepreneurial and analytical, Grant brings a commitment to relationships and ownership to drive operating results for new ventures.

Guest

Mike Collins
CEO, and Co-Founder at Alumni Ventures

Mike has been involved in almost every facet of venturing, from angel investing to venture capital, new business and product launches, and innovation consulting. He is currently CEO of Alumni Ventures Group, the managing company for our fund, and launched AV’s first alumni fund, Green D Ventures, where he oversaw the portfolio as Managing Partner and is now Managing Partner Emeritus. Mike is a serial entrepreneur who has started multiple companies, including Kid Galaxy, Big Idea Group (partially owned by WPP), and RDM. He began his career at VC firm TA Associates. He holds an undergraduate degree in Engineering Science from Dartmouth and an MBA from Harvard Business School.

To Learn More

Click the logos below for more information.

Important Disclosure Information

The Tech Optimist Podcast is for informational purposes only. It is not personalized advice and is neither an offer to sell, nor a solicitation of an offer to purchase, any security. Such offers are made only to eligible investors, pursuant to the formal offering documents of appropriate investment funds. Please consult with your advisors before making any investment with Alumni Ventures. For more information, please see here.

One or more investment funds affiliated with AV may have invested, or may in the future invest, in some of the companies featured on the Podcast. This circumstance constitutes a conflict of interest. Any testimonials or endorsements regarding AV on the Podcast are made without compensation but the providers may in some cases have a relationship with AV from which they benefit. All views expressed on the Podcast are the speaker’s own. Any testimonials or endorsements expressed on the Podcast do not represent the experience of all investors or companies with which AV invests or does business.

The Podcast includes forward-looking statements, generally consisting of any statement pertaining to any issue other than historical fact, including without limitation predictions, financial projections, the anticipated results of the execution of any plan or strategy, the expectation or belief of the speaker, or other events or circumstances to exist in the future. Forward looking statements are not representations of actual fact, depend on certain assumptions that may not be realized, and are not guaranteed to occur. Any forward- looking statements included in this communication speak only as of the date of the communication. AV and its affiliates disclaim any obligation to update, amend, or alter such forward-looking statements whether due to subsequent events, new information, or otherwise.